Vol. 10 No. 2 (2025): Educational Yield Insights & Breakthroughs (EYIB)
Articles

COVID-19 DA YALLIG‘LANISH MEDIATORLARINING QONDA O‘ZGARISHI

pdf
  • Surayyo Axmedova,
  • Dinara Olimboyeva,
  • Sohiba Abdullayeva
Surayyo Axmedova
Axmedova Toshkent Davlat Tibbiyot Universiteti
Dinara Olimboyeva
Toshkent Davlat Tibbiyot Universiteti
Sohiba Abdullayeva
Toshkent Davlat Tibbiyot Universiteti

Published 2025-12-09

Keywords

  • COVID-19, sitokin bo‘roni, IL-6, TNF-α, IL-1β, CRP, ferritin, D-dimer, yallig‘lanish mediatorlari, immunopatogenez.

Abstract

Ushbu tahliliy maqolada COVID-19 infeksiyasi jarayonida yallig‘lanish mediatorlarining qondagi o‘zgarishlari, ularning immunopatologik roli va kasallik og‘irligi bilan bog‘liqligi ilmiy adabiyotlar asosida o‘rganildi. Asosiy e’tibor interleykinlar (IL-6, IL-1β, IL-10), TNF-α, interferonlar, prokoagulyant mediatorlar (D-dimer, fibrinogen) va yallig‘lanishning “sitokin bo‘roni” mexanizmiga qaratildi. COVID-19 og‘ir kechgan bemorlarda IL-6 darajasining 10–30 barobar oshishi, ferritin va D-dimer ko‘tarilishi, limfopeniya hamda CRP miqdorining keskin ortishi kuzatilgani statistik ma’lumotlar bilan asoslandi. Ushbu mediatorlarning dinamikasi klinik holatni prognozlashda, og‘irlik darajasini aniqlashda va immunomodulyator terapiyaning samaradorligini baholashda muhim biomarker sifatida ko‘rsatildi

pdf

References

  1. Abdullateef Abdullah Z, Fouad Ali L. Role of Serum Ferritin, D-Dimer, and C-Reactive Protein Parameters in COVID 19 Severity. Arch Razi Inst. 2023 Apr 30;78(2):737-742. doi: 10.22092/ARI.2022.359731.2466. PMID: 37396735; PMCID: PMC10314272.
  2. Al-Hatemy, M. ., Mohsin, M. ., & Al-Roubaey, D. (2022). The correlation between Interleukin-6 and D-dimer, Serum ferritin, CRP in COVID-19 patients . Kufa Journal for Nursing Sciences, 12(1). https://doi.org/10.36321/kjns/2022/120118
  3. Cheng L, Li H, Li L, Liu C, Yan S, Chen H, Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. 2020 Oct;34(10):e23618. doi: 10.1002/jcla.23618. Epub 2020 Oct 19. PMID: 33078400; PMCID: PMC7595919.
  4. Eljilany, I., & Elzouki, A.-N. (2020). D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review. Vascular Health and Risk Management, 16, 455–462. https://doi.org/10.2147/VHRM.S280962
  5. Halim, C., Mirza, A. F., & Sari, M. I. (2022). The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis. Pathogens, 11(2), 195. https://doi.org/10.3390/pathogens11020195
  6. Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937175. doi: 10.1177/1753466620937175. PMID: 32615866; PMCID: PMC7336828.
  7. Jiang J, Wang J, Yao L, Lai S, Zhang X. What do we know about IL-6 in COVID-19 so far? Biophys Rep. 2021 Jun 30;7(3):193-206. doi: 10.52601/bpr.2021.200024. PMID: 37287491; PMCID: PMC10244797.
  8. Kadhim, Ali Saad1; Abdullah, Younus Jasim2,. Serum Levels of Interleukin-6, Ferritin, C-Reactive Protein, Lactate Dehydrogenase, D-Dimer, and Count of Lymphocytes and Neutrophils in COVID-19 Patients: Its Correlation to the Disease Severity. Biomedical and Biotechnology Research Journal (BBRJ) 5(1):p 69-73, Jan–Mar 2021. | DOI: 10.4103/bbrj.bbrj_188_20
  9. Laguna-Goya R, Utrero-Rico A, Talayero P, Lasa-Lazaro M, Ramirez-Fernandez A, Naranjo L, Segura-Tudela A, Cabrera-Marante O, Rodriguez de Frias E, Garcia-Garcia R, Fernández-Ruiz M, Aguado JM, Martinez-Lopez J, Lopez EA, Catalan M, Serrano A, Paz-Artal E. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9. doi: 10.1016/j.jaci.2020.07.009. Epub 2020 Jul 22. PMID: 32710975; PMCID: PMC7375283.
  10. Raman K, Kumar D, Kumar A, Saxena KN, Kohli A, Wadhawan S. Correlation of Patient Profiles and Biomarkers with Outcomes in Covid-19 Icu Patients: A Retrospective Analysis. Rom J Anaesth Intensive Care. 2022 Dec 29;28(2):71-79. doi: 10.2478/rjaic-2021-0012. PMID: 36844114; PMCID: PMC9949024.
  11. RECOVERY Collaborative Group; Abani, O., Abbas, A., Abbas, F. va boshq. (2021). Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397(10285), 1637–1645. https://doi.org/10.1016/S0140-6736(21)00676-0
  12. Samprathi M, Jayashree M. Biomarkers in COVID-19: An Up-To-Date Review. Front Pediatr. 2021 Mar 30;8:607647. doi: 10.3389/fped.2020.607647. PMID: 33859967; PMCID: PMC8042162.
  13. Snopkowska Lesniak SW, Maschio D, Henriquez-Camacho C, Moreno Cuerda V. Biomarkers for SARS-CoV-2 infection. A narrative review. Front Med (Lausanne). 2025 Mar 26;12:1563998. doi: 10.3389/fmed.2025.1563998. PMID: 40206469; PMCID: PMC11978625.
  14. Teodoro, A. G.-F., Vilar, S. G., & Farias, D. (2023). Inflammatory Response and Activation of Coagulation after SARS-CoV-2 Infection: A Review. Swiss Medical Weekly. https://smw.ch/index.php/smw/article/view/2794?utm_source=chatgpt.com
  15. Ulloque-Badaracco JR, Ivan Salas-Tello W, Al-Kassab-Córdova A, Alarcón-Braga EA, Benites-Zapata VA, Maguiña JL, Hernandez AV. Prognostic value of neutrophil-to-lymphocyte ratio in COVID-19 patients: A systematic review and meta-analysis. Int J Clin Pract. 2021 Nov;75(11):e14596. doi: 10.1111/ijcp.14596. Epub 2021 Jul 27. PMID: 34228867; PMCID: PMC9614707.
  16. Wu Z, Cao Y, Liu Z, Geng N, Pan W, Zhu Y, Shi H, Song Q, Liu B, Ma Y. Study on the predictive value of laboratory inflammatory markers and blood count-derived inflammatory markers for disease severity and prognosis in COVID-19 patients: a study conducted at a university-affiliated infectious disease hospital. Ann Med. 2024 Dec;56(1):2415401. doi: 10.1080/07853890.2024.2415401. Epub 2024 Oct 24. PMID: 39444292; PMCID: PMC11504162.